As of 2025-09-18, the Fair Value of Passage Bio Inc (PASG) is -89.39 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.03 USD, the upside of Passage Bio Inc is -1,371.61%.
With the market price of 7.03 USD and our fair value calculation, Passage Bio Inc (PASG) is not a good investment. Investing in PASG stocks now will result in a potential loss of 1,371.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -112.23 | -185.39 | -136.13 | -102.06 | -64.77 | -120.12 |
| YoY growth | -145.96% | -65.19% | 26.57% | 25.03% | 36.54% | -24.60% |
| Market Cap (mil) | 22.36 |
| P/E | |
| Forward P/E |
| EPS | -17.88 |
| Avg earnings growth rate | -24.60% |
| TTM earnings | -56.85 |